Upadacitinib 15 MG [Rinvoq]: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
6
Conditions studied
3
US states with sites
3
Countries
Phase breakdown
Phase 4 1
Not applicable 1
Conditions being studied
| Condition | Trials |
|---|---|
| Psoriasis | 2 |
| Psoriatic Arthritis | 1 |
| Psoriatic Arthritis (PsA | 1 |
| Rheumatoid Arthritis (RA | 1 |
| Rheumatoid arthritis | 1 |
| Spondyloarthritis, Axial | 1 |
Recruiting trials involving Upadacitinib 15 MG [Rinvoq]
- A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
- Efficacy Of Upadacitinib In Psoriatic Arthritis And Comparison To Rheumatoid Arthritis.
Common questions
How many recruiting trials involve Upadacitinib 15 MG [Rinvoq]?
2 recruiting trials across 6 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.